Curaleaf Formally Launches Hostile Takeover Bid for Aurora Cannabis at US$4.00/Share
CURLF sits 73% above its 52-week low of $5.4.
Summary
Curaleaf formally launched its hostile takeover bid for Aurora Cannabis, offering US$4.00 per share (45% premium) with a December 1, 2026 expiry. The bid includes a US$5.00 cap price and requires at least 50% of shares tendered.
Key Events · M&A and Partnerships · CURLF
-
Formal Takeover Bid Launched
The formal offer and take-over bid circular for Aurora Cannabis has been filed, offering 0.3463 Curaleaf shares plus US$0.75 cash per Aurora share, implying US$4.00 per share total consideration.
-
45% Premium to Unaffected Price
The offer represents a 45% premium to Aurora's 30-day VWAP of US$2.75 as of August 10, 2026, and a 110% premium on an ex-cash basis.
-
Offer Expires December 1, 2026
The offer remains open until 5:00 p.m. Mountain Time on December 1, 2026, unless extended, varied, or withdrawn.
-
Cap Price and Adjustment Mechanism
The offer is subject to a maximum value of US$5.00 per Aurora share. If Curaleaf's 20-day VWAP exceeds C$17.05, the exchange ratio adjusts to maintain the cap price.
Analysis · CURLF · Life Sciences
The hostile takeover bid for Aurora Cannabis has now been formally commenced, with the offer and take-over bid circular filed with regulators. Valued at US$4.00 per share—a 45% premium to Aurora's unaffected share price—the offer expires December 1, 2026. It is not subject to financing or due diligence conditions, and at least US$40 million in annual cost synergies have been identified. This formal launch escalates the hostile situation and puts the offer directly in front of Aurora shareholders, increasing pressure on Aurora's board to engage.
How filings like this one have moved
In the 30 days to Oct 17, 2026, 44.5% of the 299 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.30%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CURLF was trading at $9.34 on OTC in the Life Sciences sector, with a market capitalization of approximately $2.5B. The 52-week trading range was $5.40 to $15.15. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.